Findings from the CheckMate 9DW trial support the FDA approval of nivolumab and ipilimumab in unresectable hepatocellular carcinoma ...

L ike many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few—in ...

Hepatocellular carcinoma is more likely to develop in men than in women. It becomes more common as you get older. Fibrolamellar carcinoma is a rare type of HCC. Fibrolamellar carcinoma tends to ...